Skip to main content
SKIN logo
SKIN
(NASDAQ)
SkinHealth Systems Inc.
$0.66-- (--)
Loading... - Market loading

SkinHealth Systems (SKIN) Company Profile

Complete business overview, executive team, trading details, and corporate information.

SkinHealth Systems Inc.
SKINNasdaq Stock MarketConsumer StaplesHousehold & Personal Products

About SkinHealth Systems

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock
Share ClassClass A Shares

Contact Information

Phone800 603 4996
Address
3600 E. Burnett Street Long Beach, California 90815 United States

Corporate Identifiers

CIK0001818093
CUSIP88331L108
ISINUS88331L1089
EIN85-1908962
SIC3841

Leadership Team & Key Executives

Pedro Malha
Chief Executive Officer and President
Michael P. Monahan
Chief Financial Officer
Sheri Lewis
Chief Operations, Quality and Technology Officer
Paul Bokota J.D.
Senior Vice President and General Counsel
Ronald Menezes
Chief Revenue Officer and Executive Officer
Whitney Cypes
Chief Brand and Clinical Innovation Officer